| Prev Close | 35.55 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 31.08 / 80.25 |
| Avg Volume | 722.70K |
| Exchange | NASDAQ |
| Shares Outstanding | 37.28M |
| Market Cap | 1.32B |
| EPS | 0.10 |
| P/E Ratio | 48.58 |
| Div & Yield | N.A. (N.A) |
Latest News
Perilous Reversal Stock: Pacira Pharmaceuticals (PCRX)
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "perilous reversal" (up big yesterday but down big today) candidate
Trade-Ideas: Pacira Pharmaceuticals (PCRX) Is Today's "Barbarian At The Gate" Stock
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Pacira Pharmaceuticals (PCRX) Flagged As Strong On High Volume
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a strong on high relative volume candidate
September 16th Options Now Available For Pacira Pharmaceuticals (PCRX)
Investors in Pacira Pharmaceuticals Inc. saw new options become available today, for the September 16th expiration.
Pacira Pharmaceuticals (PCRX) Is Today's Dead Cat Bounce Stock
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Today's Dead Cat Bounce Stock Is Pacira Pharmaceuticals (PCRX)
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Pacira Pharmaceuticals (PCRX) Is Weak On High Volume Today
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a weak on high relative volume candidate
Pacira Pharmaceuticals (PCRX) Showing Signs Of Perilous Reversal Today
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "perilous reversal" (up big yesterday but down big today) candidate
Bearish Bets: 5 Stocks That Look Like Good Buys on the Short Side
UFS, PCRX, AAL, BEN and BHE were all recently downgraded by TheStreet’s Quant Ratings.
Today's Dead Cat Bounce Stock Is Pacira Pharmaceuticals (PCRX)
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Ratings Changes Today
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABCD, ABX, AEG, AMBC, AZN, BK, CBG, CBT, CNA, CSTE, DO, EEP, GBX, GRC, HHC, NWFL, OFIX, RJF, ROG, RVSB, SBAC, SCCO, SLM, TOT Downgrades: ATRC, BSFT, CZNC, PCRX, VICR, WTM Initiations: RYAM Read on to get TheStreet Quant Ratings' detailed report:
Today's Dead Cat Bounce Stock: Pacira Pharmaceuticals (PCRX)
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate
PCRX: Insiders vs. Shorts
The most recent short interest data was recently released by the NASDAQ for the 03/31/2016 settlement date, and Pacira Pharmaceuticals Inc. is one of the most shorted stocks of the Russell 3000, based on 10.18 "days to cover" versus the median component at 5.89.
Pacira Pharmaceuticals (PCRX) Marked As A Dead Cat Bounce Stock
Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate
New Analysis Shows Use Of EXPAREL Reduces Length Of Hospital Stay And Improves Discharge Status Compared To Standard Analgesic Modality In Total Knee Arthroplasty
Data Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons
Pacira Pharmaceuticals (PCRX) Stock Price Target Cut at Jefferies
Jefferies lowered its price target on Pacira Pharmaceuticals (PCRX) stock and maintained its ‘buy’ rating.
Pacira Pharmaceuticals (PCRX) Stock Slumps Following Q4 Results
Pacira Pharmaceuticals (PCRX) stock is falling on Thursday after the company reported its 2015 fourth quarter results before today’s opening bell.
